What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Could FcRn blockers become the next biologics blockbuster class after interleukin inhibitors and JAKs? A new frontier is emerging in the world of biologic therapies. After years of dominance by interleukin inhibitors… byVenkateshOctober 25, 2025